EVENT
WPI-Bio2Q Open Seminar, Harvey Lodish, Ph.D.
June 19, 2024
On Wednesday, June 12, the Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held an open seminar at Shinanomachi Campus .
16:00 -17:30 Wednesday, June 12, 2024
“New Technologies and Building Successful Biotechnology Companies to Treat Disease: A Personal History”
Harvey F. Lodish, PhD
Professor of Biology and Professor of Biological Engineering, Massachusetts Institute of Technology
Lead author, “Molecular Cell Biology”
Founder/scientific board member: Genzyme, Millennium Pharmaceuticals, Rubius Therapeutics, Tevard
Prof. Lodish highlighted the connection between academia and entrepreneurship in biotechnology, covering key aspects of starting a biotech company, intellectual property, and assembling a team with diverse expertise. The importance of scientists leveraging their expertise by consulting for or founding companies and the advantage of research institutes being located near biotech companies for collaboration was also discussed.
SHARE
More Bio2Q News
The 2nd Anniversary of WPI-Bio2Q
It will soon be two years since WPI-Bio2Q was officially inaugurated on November 11, 2022 To celebrate this anniversary, Bio2Q members from...
The 13th WPI Science Symposium "The world expands through science"
The 13th WPI Science Symposium will be held on Saturday, November 16, 2024 at Kyoto University. The WPI Science Symposium is an annual ev...
New booklets for young readers published
Two new issues of the ”Booklets For Young Readers”, ISSUE 05 (Professor Makoto Arita, Bio-1 Core Director) and ISSUE 06 (Professor Toshiro S...
[WPI-Bio2Q Open Seminar] Sin-Hyeog Im, Ph.D. (Keio and WPI-Bio2Q members only)
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold an open seminar as follows. Date & Time F...
WPI-Bio2Q Social Event (2024.9.6)
WPI-Bio2Q LUNCH TIME was held as one of our social events. Date & Time: Friday, September 6, 2024, 12:00-13:00 Venue: Bio2Q Office, ...